Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Harrison

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Neuroreport|August 16, 2000
Sulcogyral variation in NMDA receptor 2A/B subunit immunoreactivity in human brainS M Sisodiya, J Heffernan, P J Harrison, et al.
Synapse (New York, N.Y.)|September 28, 2001
Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophreniaS L Eastwood, P W Burnet, R Gittins, et al.
Brain Research. Molecular Brain Research|January 1, 1991
Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistryP J Harrison, A J Barton, A Najlerahim, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2012
Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibitionL M Laatikainen, T Sharp, D M Bannerman, et al.
Neuroreport|June 27, 1994
AMPA glutamate receptors and their flip and flop mRNAs in human hippocampusS L Eastwood, P W Burnet, J Beckwith, et al.
Neurochemistry International|September 1, 1997
Critical issues in the antisense inhibition of brain gene expression in vivo: experiences targetting the 5-HT1A receptorS M Le Corre, P W Burnet, R Meller, et al.
The British Journal of Mathematical and Statistical Psychology|May 1, 1976
A model for institutional disturbancesE C Zeeman, C S Hall, P J Harrison, et al.
Journal of Neurochemistry|February 1, 1994
The effects of Alzheimer's disease, other dementias, and premortem course on beta-amyloid precursor protein messenger RNA in frontal cortexP J Harrison, A J Barton, A W Procter, et al.
Psychopharmacology|February 24, 2001
Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapineA L Sharpley, C M Vassallo, E C Pooley, et al.
Psychiatric Genetics|July 21, 1999
Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorderP W Burnet, K A Smith, P J Cowen, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Neuroreport|August 16, 2000
Sulcogyral variation in NMDA receptor 2A/B subunit immunoreactivity in human brainS M Sisodiya, J Heffernan, P J Harrison, et al.
Synapse (New York, N.Y.)|September 28, 2001
Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophreniaS L Eastwood, P W Burnet, R Gittins, et al.
Brain Research. Molecular Brain Research|January 1, 1991
Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistryP J Harrison, A J Barton, A Najlerahim, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2012
Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibitionL M Laatikainen, T Sharp, D M Bannerman, et al.
Neuroreport|June 27, 1994
AMPA glutamate receptors and their flip and flop mRNAs in human hippocampusS L Eastwood, P W Burnet, J Beckwith, et al.
Neurochemistry International|September 1, 1997
Critical issues in the antisense inhibition of brain gene expression in vivo: experiences targetting the 5-HT1A receptorS M Le Corre, P W Burnet, R Meller, et al.
The British Journal of Mathematical and Statistical Psychology|May 1, 1976
A model for institutional disturbancesE C Zeeman, C S Hall, P J Harrison, et al.
Journal of Neurochemistry|February 1, 1994
The effects of Alzheimer's disease, other dementias, and premortem course on beta-amyloid precursor protein messenger RNA in frontal cortexP J Harrison, A J Barton, A W Procter, et al.
Psychopharmacology|February 24, 2001
Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapineA L Sharpley, C M Vassallo, E C Pooley, et al.
Psychiatric Genetics|July 21, 1999
Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorderP W Burnet, K A Smith, P J Cowen, et al.
Pageof 20